Clinical Trials Logo
  1. Home
  2. Clinical High Risk for Psychosis
  3. NCT02047539

Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis

Clinical High Risk for Psychosis Clinical Trial

Official title:
Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Patients With the Clinical Risk Syndrome for Psychosis

Clinical Trial Summary

The primary objective of this study is to determine whether aspirin is effective in alleviating symptoms of the clinical high risk (CHR) syndrome for psychosis. The investigators further aim to determine whether it may delay or prevent the onset of psychosis in those currently experiencing CHR symptoms. As secondary measures the investigators aim to collect laboratory studies of inflammation markers and genetic samples to determine whether certain genetic profiles correlate with risk for psychosis, or response to aspirin treatment.

Clinical Trial Description

Patients will be randomly assigned to either active treatment (aspirin) or placebo. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02047539
Study type Interventional
Source Yale University
Contact
Status Terminated
Phase Early Phase 1
Start date January 2015
Completion date March 2021
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03829527 - Evaluation of the Treatment Approach ROBIN N/A
Recruiting NCT05827900 - Metacognitive Training in Ultra-high Risk N/A
Recruiting NCT02951208 - tDCS Coupled With Virtual Rehabilitation for Negative Symptoms in At-Risk Youth N/A
Completed NCT03983421 - Feasibility of an Early Detection Program for Early Psychosis on a College Campus
Recruiting NCT06037993 - Endocannabinoid Activity Remodulation for Psychosis Liability in Youth N/A
Completed NCT02404194 - Targeted Cognitive Training in Clinical High Risk (CHR) for Psychosis N/A
Completed NCT04444180 - The Predictive Role of Self-representation in Transition of Individuals at Clinical High Risk for Psychosis
Recruiting NCT05114733 - Individualized Vocational and Educational Support and Training for Clinical High Risk for Psychosis (InVEST) N/A
Completed NCT03303456 - Using Mobile Technology to Enhance Early Psychosis Treatment Delivery N/A
Completed NCT03286595 - Smartphone Applications Youth With Early Psychosis in Community Outpatient Settings N/A
Terminated NCT02557945 - Gabapentin in Patients at Clinical Risk for Psychosis Phase 1/Phase 2
Completed NCT03321617 - Glutamate Reducing Interventions in Schizophrenia Phase 1